Teradyne, Inc. $TER Shares Bought by CoreCap Advisors LLC

CoreCap Advisors LLC grew its holdings in shares of Teradyne, Inc. (NASDAQ:TERFree Report) by 6,479.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,816 shares of the company’s stock after buying an additional 8,682 shares during the period. CoreCap Advisors LLC’s holdings in Teradyne were worth $4,266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in the business. Integrated Wealth Concepts LLC boosted its holdings in Teradyne by 12.8% in the first quarter. Integrated Wealth Concepts LLC now owns 4,136 shares of the company’s stock valued at $342,000 after purchasing an additional 468 shares in the last quarter. Caxton Associates LLP purchased a new stake in shares of Teradyne during the 1st quarter worth approximately $297,000. Cresset Asset Management LLC lifted its position in shares of Teradyne by 11.6% during the 2nd quarter. Cresset Asset Management LLC now owns 6,759 shares of the company’s stock worth $608,000 after buying an additional 702 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Teradyne by 467.1% in the 2nd quarter. NewEdge Advisors LLC now owns 3,408 shares of the company’s stock valued at $306,000 after buying an additional 2,807 shares in the last quarter. Finally, Treasurer of the State of North Carolina boosted its holdings in shares of Teradyne by 5.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 75,125 shares of the company’s stock valued at $6,755,000 after buying an additional 3,651 shares in the last quarter. 99.77% of the stock is owned by institutional investors and hedge funds.

Teradyne Price Performance

TER stock opened at $389.39 on Thursday. The company has a fifty day moving average price of $383.32 and a 200 day moving average price of $341.19. Teradyne, Inc. has a 12 month low of $103.33 and a 12 month high of $487.91. The company has a market cap of $60.88 billion, a price-to-earnings ratio of 53.41, a price-to-earnings-growth ratio of 0.82 and a beta of 1.78.

Teradyne (NASDAQ:TERGet Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $2.47 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.38. Teradyne had a net margin of 25.77% and a return on equity of 39.93%. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Teradyne’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.57 EPS. Teradyne has set its Q3 2026 guidance at 1.850-2.150 EPS. As a group, analysts anticipate that Teradyne, Inc. will post 9.1 earnings per share for the current year.

Teradyne News Summary

Here are the key news stories impacting Teradyne this week:

  • Positive Sentiment: Favorable earnings revisions support upside potential. Analyst estimate revisions indicate improving expectations for Teradyne, which could help sustain the stock’s recent upward momentum. The company recently exceeded quarterly revenue and EPS estimates, with revenue more than doubling year over year. Why Teradyne Might Be Well Poised for a Surge
  • Positive Sentiment: AI and semiconductor demand remain key growth drivers. Teradyne’s chip-testing business is benefiting from increasing demand tied to artificial intelligence, while its robotics operations provide an additional long-term growth opportunity. These trends are supporting the premium investors have placed on TER. Teradyne Is Overvalued at 10.36X Price-to-Sales
  • Neutral Sentiment: Relative valuation comparisons remain favorable in some respects. Commentary comparing Teradyne with KLA suggests investors are paying up for stronger expected growth, even as valuation leadership within the chip-equipment sector shifts. This reinforces TER’s growth appeal but does not provide a new company-specific catalyst. How KLA Went From Cheaper Than Teradyne to the Pricier Stock
  • Negative Sentiment: Elevated valuation creates downside risk. Teradyne trades at roughly 10.36 times sales and at a high earnings multiple, leaving the stock vulnerable if AI-related growth slows, guidance disappoints, or investors rotate away from expensive technology shares. Teradyne Is Overvalued at 10.36X Price-to-Sales

Insider Activity

In other news, CEO Gregory Stephen Smith sold 4,000 shares of the stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $423.03, for a total transaction of $1,692,120.00. Following the completion of the sale, the chief executive officer owned 120,470 shares in the company, valued at approximately $50,962,424.10. This represents a 3.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shannon John Poulin sold 656 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $355.00, for a total value of $232,880.00. Following the transaction, the insider directly owned 15,722 shares in the company, valued at approximately $5,581,310. This represents a 4.01% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 14,261 shares of company stock valued at $5,187,344 in the last quarter. Insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Citigroup lifted their price target on shares of Teradyne from $325.00 to $400.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Weiss Ratings downgraded shares of Teradyne from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, July 20th. Zacks Research raised Teradyne from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. UBS Group lifted their target price on Teradyne from $440.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $465.00 target price on shares of Teradyne in a report on Tuesday, July 28th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $396.80.

Read Our Latest Report on Teradyne

Teradyne Company Profile

(Free Report)

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.

Recommended Stories

Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TERFree Report).

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.